MER3101: MAS-1 ADJUVANTED ANTIGEN-SPECIFIC IMMUNOTHERAPEUTIC FOR PREVENTION AND TREATMENT OF TYPE 1 DIABETES
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
UCD Barbara Davis Center
University of Colorado Hospital
Principal Investigator
Peter Gottlieb, MD
Study ID
Protocol Number: 15-1352
More information available at ClinicalTrials.gov: NCT03624062
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers